Investing in new frontiers of cancer research
These are
exciting times!
Characterized by unprecedented collaboration between clinicians, research scientists, engineers, and mathematicians. By working together, they are breaking down silos, fostering innovation, making groundbreaking discoveries, and transforming the landscape of cancer research- thereby creating new opportunities for cancer patients.
Priority
research areas
With your generous support, the Rosalind and Morris Goodman Cancer Institute is posed to lead the way on these five high priority areas:
Lung cancer
with an intent to cure
Metabolism & cancer
a next frontier of cancer therapeutics
High fatality cancers
tackling the toughest challenges in cancer research
RNA therapeutics
developing new drugs for previously undruggable cancer targets
AI and deep learning
driving the next precision oncology breakthroughs
These strategic areas of investment build on the GCI’s strong foundation of research expertise, our track record of innovation and partnerships and our existing facilities and infrastructure. We believe these areas provide the best opportunity to deliver on significant results over the next five to ten years.
Your support
makes a difference
Your leadership support will result in tangible benefits to cancer patients everywhere– through earlier detection, expanded therapeutic development, more personalized medicine, and improved prediction, prevention, and survivorship.
Get in touch with our team
to see how you can contribute
to our major campaign
Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte
